Tower Research Capital (TRC)’s Crinetics Pharmaceuticals CRNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$367K Buy
12,768
+12,235
+2,295% +$352K 0.01% 1238
2025
Q1
$17.9K Sell
533
-6,879
-93% -$231K ﹤0.01% 3084
2024
Q4
$379K Buy
7,412
+6,960
+1,540% +$356K 0.01% 1251
2024
Q3
$23.1K Sell
452
-12,404
-96% -$634K ﹤0.01% 3163
2024
Q2
$576K Buy
12,856
+12,281
+2,136% +$550K 0.01% 1223
2024
Q1
$26.9K Sell
575
-3,028
-84% -$142K ﹤0.01% 2740
2023
Q4
$128K Buy
3,603
+2,039
+130% +$72.5K ﹤0.01% 2442
2023
Q3
$46.5K Sell
1,564
-2,980
-66% -$88.6K ﹤0.01% 2608
2023
Q2
$81.9K Buy
4,544
+2,617
+136% +$47.2K ﹤0.01% 2173
2023
Q1
$31K Buy
1,927
+1,009
+110% +$16.2K ﹤0.01% 2948
2022
Q4
$17K Sell
918
-9,271
-91% -$172K ﹤0.01% 3264
2022
Q3
$200K Buy
10,189
+5,687
+126% +$112K ﹤0.01% 1928
2022
Q2
$84K Sell
4,502
-12,242
-73% -$228K ﹤0.01% 2420
2022
Q1
$368K Buy
16,744
+13,226
+376% +$291K ﹤0.01% 1337
2021
Q4
$100K Sell
3,518
-247
-7% -$7.02K ﹤0.01% 2220
2021
Q3
$79K Buy
3,765
+1,881
+100% +$39.5K ﹤0.01% 2595
2021
Q2
$36K Buy
1,884
+1,233
+189% +$23.6K ﹤0.01% 3296
2021
Q1
$10K Sell
651
-5,422
-89% -$83.3K ﹤0.01% 4359
2020
Q4
$86K Sell
6,073
-16,811
-73% -$238K ﹤0.01% 2495
2020
Q3
$359K Buy
22,884
+19,582
+593% +$307K ﹤0.01% 2017
2020
Q2
$58K Buy
+3,302
New +$58K ﹤0.01% 2930
2019
Q4
Sell
-2,691
Closed -$40K 3661
2019
Q3
$40K Buy
2,691
+2,194
+441% +$32.6K ﹤0.01% 1955
2019
Q2
$12K Sell
497
-572
-54% -$13.8K ﹤0.01% 2448
2019
Q1
$24K Sell
1,069
-739
-41% -$16.6K ﹤0.01% 2161
2018
Q4
$54K Buy
+1,808
New +$54K ﹤0.01% 1242